top of page
CANDO (Controlling Abnormal Network Dynamics using Optogenetics) is a world-class, multi-site, cross-disciplinary project to develop a cortical implant for optogenetic neural control. The goal is to create a first-in-human trial in patients with focal epilepsy. This seven year, £10M Innovative Engineering for Health Award, funded by the Wellcome Trust and the Engineering and Physical Sciences Research Council (EPSRC) involves a team of over 30 neuroscientists, engineers and clinicians based at Newcastle University, Imperial College London, University College London and The Newcastle Hospitals NHS Foundation Trust.
More about the project: http://www.cando.ac.uk/
bottom of page